Online first
Review paper
Published online: 2024-11-07

open access

Page views 913
Article views/downloads 948
Get Citation

Connect on Social Media

Connect on Social Media

Metamizole (dipyrone) for multimodal analgesia in postoperative pain in adults

Anna Dizner-Golab1, Dariusz Kosson12, Barbara Lisowska3

Abstract

Background: Metamizole (dipyrone) is a non-opioid analgesic used in perioperative analgesia in some countries. The drug has analgesic, antipyretic, and spasmolytic effects. The complex mechanism has not been fully explained yet. Presumably, the analgesic effect is based on the inhibition of the activity of COX-1 and COX-2 cyclooxygenases and prostaglandin synthesis. Moreover, the activation of the opioidergic, cannabinoid, and endovanilloid systems also plays an important role. Metamizole is a relatively safe analgesic, although it is not completely free of adverse effects. Among them, the most serious and controversial are myelotoxicity, idiosyncratic drug-induced liver injury (DILI), and allergic reactions. The aim and objective is to present data on the use of metamizole for treating acute postoperative pain in adults.

Methods: The search, which included PubMed/Medline, Web of Science, and Scopus databases, has been performed to find information about the use of metamizole in perioperative pain management.

Results: The data on the role of metamizole in perioperative pain management seems to be insufficient. Moreover, most studies concerning the use of metamizole focus on postoperative administration regimens. The use of metamizole in preventive and multimodal analgesia is represented by sparse or controversial data.

Conclusions: There is some evidence in the literature of the effectiveness of metamizole in the treatment of postoperative pain. Moreover, experience based on clinical practice indicates the high usefulness of metamizole as a perioperative analgesic. Thus metamizole could be considered an important part of multimodal analgesia. Although this drug could be a dominant component of multimodal analgesia, its use is limited by the occurrence of serious adverse reactions. Therefore, special precautions should be taken when using it. However, there is a need for further research, especially to determine its effectiveness in multimodal and preventive analgesia regimens.

Article available in PDF format

View PDF Download PDF file

References

  1. Kötter T, da Costa BR, Fässler M, et al. Metamizole-associated adverse events: a systematic review and meta-analysis. PLoS One. 2015; 10(4): e0122918.
  2. Lutz M. Metamizole (dipyrone) and the liver: a review of the literature. J Clin Pharmacol. 2019; 59(11): 1433–1442.
  3. Andrade S, Bartels DB, Lange R, et al. Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther. 2016; 41(5): 459–477.
  4. European Medicines Agency. https://www.ema.europa.eu/en/homepage (13.08.2024).
  5. Levy M, Zylber-Katz E, Rosenkranz B. Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet. 1995; 28(3): 216–234.
  6. Zylber-Katz E, Granit L, Stessman J, et al. Effect of age on the pharmacokinetics of dipyrone. Eur J Clin Pharmacol. 1989; 36(5): 513–516.
  7. Hong GS, Stein K, Lysson M, et al. A comparative study about the immunomodulatory effects of tramadol and metamizole in a murine model of postoperative ileus. Lab Anim. 2019; 53(6): 610–618.
  8. Brogden RN. Pyrazolone derivatives. Drugs. 1986; 32 Suppl 4: 60–70.
  9. Rogosch T, Sinning C, Podlewski A, et al. Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem. 2012; 20(1): 101–107.
  10. Pierre SC, Schmidt R, Brenneis C, et al. Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol. 2007; 151(4): 494–503.
  11. dos Santos GG, Dias EV, Teixeira JM, et al. The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: neuronal K(ATP) channel opening and CB(1) receptor activation. Eur J Pharmacol. 2014; 741: 124–131.
  12. Gonçalves Dos Santos G, Vieira WF, Vendramini PH, et al. Dipyrone is locally hydrolyzed to 4-methylaminoantipyrine and its antihyperalgesic effect depends on CB and kappa-opioid receptors activation. Eur J Pharmacol. 2020; 874: 173005.
  13. Russo S, de Azevedo WF. Computational analysis of dipyrone metabolite 4-aminoantipyrine as a cannabinoid receptor 1 agonist. Curr Med Chem. 2020; 27(28): 4741–4749.
  14. Schenk SA, Dick F, Herzog C, et al. Active metabolites of dipyrone induce a redox-dependent activation of the ion channels TRPA1 and TRPV1. Pain Rep. 2019; 4(3): e720.
  15. Maione S, Radanova L, De Gregorio D, et al. Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice. Eur J Pharmacol. 2015; 748: 115–122.
  16. Malvar Dd, Soares DM, Fabrício ASC, et al. The antipyretic effect of dipyrone is unrelated to inhibition of PGE(2) synthesis in the hypothalamus. Br J Pharmacol. 2011; 162(6): 1401–1409.
  17. Valenzuela F, García-Saisó S, Lemini C, et al. Metamizol acts as an ATP sensitive potassium channel opener to inhibit the contracting response induced by angiotensin II but not to norepinephrine in rat thoracic aorta smooth muscle. Vascul Pharmacol. 2005; 43(2): 120–127.
  18. Gulmez SE, Gurdal H, Tulunay FC. Airway smooth muscle relaxations induced by dipyrone. Pharmacology. 2006; 78(4): 202–208.
  19. Gulmez SE, Celik G, Misirligil Z, et al. Dipyrone improves small airway function in asthmatic patients with moderate obstruction. J Investig Allergol Clin Immunol. 2007; 17(4): 242–248.
  20. Vinagre AM, Collares EF. Effect of selective β-adrenoceptor blockade and surgical resection of the celiac-superior mesenteric ganglion complex on delayed liquid gastric emptying induced by dipyrone, 4-aminoantipyrine, and antipyrine in rats. Braz J Med Biol Res. 2016; 49(3).
  21. Collares EF, Troncon LEA. Effects of dipyrone on the digestive tract. Braz J Med Biol Res. 2019; 52(2): e8103.
  22. Stammschulte T, Ludwig WD, Mühlbauer B, et al. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012. Eur J Clin Pharmacol. 2015; 71(9): 1129–1138.
  23. Hoffmann F, Bantel C, Jobski K. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985–2017. Basic Clin Pharmacol Toxicol. 2020; 126(2): 116–125.
  24. Björnsson ES. Liver injury associated with the analgetic drug metamizole. Br J Clin Pharmacol. 2020; 86(7): 1248–1250.
  25. Sebode M, Reike-Kunze M, Weidemann S, et al. Metamizole: an underrated agent causing severe idiosyncratic drug-induced liver injury. Br J Clin Pharmacol. 2020; 86(7): 1406–1415.
  26. Blanca-López N, Pérez-Sánchez N, Agúndez JA, et al. Allergic reactions to metamizole: immediate and delayed responses. Int Arch Allergy Immunol. 2016; 169(4): 223–230.
  27. Lopes A, Paulino M, Spínola Santos A, et al. Delayed postoperative reactions to metamizole: a diagnostic challenge. Eur Ann Allergy Clin Immunol. 2023 [Epub ahead of print].
  28. Mukherjee S, Sood S. A controlled evaluation of orally administered aspirin, dipyrone and placebo in patients with post-operative pain. Curr Med Res Opin. 1980; 6(9): 619–623.
  29. Mehta SD. A randomized double-blind placebo-controlled study of dipyrone and aspirin in post-operative orthopaedic patients. J Int Med Res. 1986; 14(2): 63–66.
  30. Daftary SN, Mehta AC, Nanavati M. A controlled comparison of dipyrone and paracetamol in post-episiotomy pain. Curr Med Res Opin. 1980; 6(9): 614–618.
  31. Planas ME, Gay-Escoda C, Bagán JV, et al. Oral metamizol (1 g and 2 g) versus ibuprofen and placebo in the treatment of lower third molar surgery pain: randomised double-blind multi-centre study. Cooperative Study Group. Eur J Clin Pharmacol. 1998; 53(6): 405–409.
  32. Tempel G, von Hundelshausen B, Reeker W. The opiate-sparing effect of dipyrone in post-operative pain therapy with morphine using a patient-controlled analgesic system. Intensive Care Med. 1996; 22(10): 1043–1047.
  33. Blendinger I, Eberlein HJ. Comparison of intravenous acetylsalicylic acid and dipyrone in postoperative pain: an interim report. Br J Clin Pharmacol. 1980; 10 Suppl 2(Suppl 2): 339S–341S.
  34. Gómez-Jiménez J, Franco-Patino R, Chargoy-Vera J, et al. Clinical efficacy of mild analgesics in pain following gynaecological or dental surgery: report on multicentre studies. Br J Clin Pharmacol. 1980; 10 Suppl 2(Suppl 2): 355S–358S.
  35. Landwehr S, Kiencke P, Giesecke T, et al. A comparison between IV paracetamol and IV metamizol for postoperative analgesia after retinal surgery. Curr Med Res Opin. 2005; 21(10): 1569–1575.
  36. Kampe S, Warm M, Landwehr S, et al. Clinical equivalence of IV paracetamol compared to IV dipyrone for postoperative analgesia after surgery for breast cancer. Curr Med Res Opin. 2006; 22(10): 1949–1954.
  37. Patel CV, Koppikar MG, Patel MS, et al. Management of pain after abdominal surgery: dipyrone compared with pethidine. Br J Clin Pharmacol. 1980; 10 Suppl 2(Suppl 2): 351S–354S.
  38. Rodriguez MJ, Torre MRD, Perez-Iraola P, et al. Comparative study of tramadol versus NSAIDS as intravenous continuous infusion for managing postoperative pain. Current Therapeutic Research. 1993; 54(4): 375–383.
  39. Bagán JV, López Arranz JS, Valencia E, et al. Clinical comparison of dexketoprofen trometamol and dipyrone in postoperative dental pain. J Clin Pharmacol. 1998; 38(S1): 55S–64S.
  40. Saray A, Büyükkocak U, Cinel I, et al. Diclofenac and metamizol in postoperative analgesia in plastic surgery. Acta Chir Plast. 2001; 43(3): 71–76.
  41. Rawal N, Allvin R, Amilon A, et al. Postoperative analgesia at home after ambulatory hand surgery: a controlled comparison of tramadol, metamizol, and paracetamol. Anesth Analg. 2001; 92(2): 347–351.
  42. Torres LM, Rodríguez MJ, Montero A, et al. Efficacy and safety of dipyrone versus tramadol in the management of pain after hysterectomy: a randomized, double-blind, multicenter study. Reg Anesth Pain Med. 2001; 26(2): 118–124.
  43. Grundmann U, Wörnle C, Biedler A, et al. The efficacy of the non-opioid analgesics parecoxib, paracetamol and metamizol for postoperative pain relief after lumbar microdiscectomy. Anesth Analg. 2006; 103(1): 217–222.
  44. Jovic R, Dragicevic D, Komazec Z, et al. Ketoprofen is superior to metamizole in relieving postoperative pain after head and neck tumor operation. J BUON. 2008; 13(4): 519–523.
  45. Soltesz S, Gerbershagen MU, Pantke B, et al. Parecoxib versus dipyrone (metamizole) for postoperative pain relief after hysterectomy : a prospective, single-centre, randomized, double-blind trial. Clin Drug Investig. 2008; 28(7): 421–428.
  46. Sener M, Yilmazer C, Yilmaz I, et al. Efficacy of lornoxicam for acute postoperative pain relief after septoplasty: a comparison with diclofenac, ketoprofen, and dipyrone. J Clin Anesth. 2008; 20(2): 103–108.
  47. Sener M, Yilmazer C, Yilmaz I, et al. Patient-controlled analgesia with lornoxicam vs. dipyrone for acute postoperative pain relief after septorhinoplasty: a prospective, randomized, double-blind, placebo-controlled study. Eur J Anaesthesiol. 2008; 25(3): 177–182.
  48. Noronha VRS, Gurgel GdS, Alves LC, et al. Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial. Med Oral Patol Oral Cir Bucal. 2009; 14(8): e411–e415.
  49. Korkmaz Dilmen O, Tunali Y, Cakmakkaya OS, et al. Efficacy of intravenous paracetamol, metamizol and lornoxicam on postoperative pain and morphine consumption after lumbar disc surgery. Eur J Anaesthesiol. 2010; 27(5): 428–432.
  50. Karaman Y, Çukurova I, Demirhan E, et al. Efficacy of dexketoprofen trometamol for acute postoperative pain relief after ENT surgery: acomparision with paracetamol and metamizole. Nobel Medicus. 2010; 6(2): 47–52.
  51. Brodner G, Gogarten W, Van Aken H, et al. Efficacy of intravenous paracetamol compared to dipyrone and parecoxib for postoperative pain management after minor-to-intermediate surgery: a randomised, double-blind trial. Eur J Anaesthesiol. 2011; 28(2): 125–132.
  52. Abdulla S, Eckhardt R, Netter U, et al. A randomized, double-blind, controlled trial on non-opioid analgesics and opioid consumption for postoperative pain relief after laparoscopic cholecystectomy. Acta Anaesthesiol Belg. 2012; 63(1): 43–50.
  53. Abdulla S, Eckhardt R, Netter U, et al. Efficacy of three IV non-opioid-analgesics on opioid consumption for postoperative pain relief after total thyroidectomy: a randomised, double-blind trial. Middle East J Anaesthesiol. 2012; 21(4): 543–552.
  54. Abdulla S, Eckhardt R, Netter U, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy of nonopioid analgesics on pain following arthroscopic knee surgery. Pain Res Treat. 2012; 2012: 305821.
  55. Santonocito C, Noto A, Crimi C, et al. Remifentanil-induced postoperative hyperalgesia: current perspectives on mechanisms and therapeutic strategies. Local Reg Anesth. 2018; 11: 15–23.
  56. Oreskovic Z, Bicanic G, Hrabac P, et al. Treatment of postoperative pain after total hip arthroplasty: comparison between metamizol and paracetamol as adjunctive to opioid analgesics-prospective, double-blind, randomised study. Arch Orthop Trauma Surg. 2014; 134(5): 631–636.
  57. Dilmen OK, Akcil EF, Tunali Y, et al. Postoperative analgesia for supratentorial craniotomy. Clin Neurol Neurosurg. 2016; 146: 90–95.
  58. Geißler K, Ducke M, Volk GF, et al. Pain on the first postoperative day after tonsillectomy in adults: A comparison of metamizole versus etoricoxib as baseline analgesic. PLoS One. 2019; 14(8): e0221188.
  59. Gostian AO, Loeser J, Tholen C, et al. Postoperative pain after tonsillectomy - the value of standardized analgesic treatment protocols. Auris Nasus Larynx. 2020; 47(6): 1009–1017.
  60. Steffen P, Schuhmacher I, Weichel T, et al. [Differential administration of non-opioids in postoperative analgesia, I. Quantification of the analgesic effect of metamizole using patient-controlled analgesia]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996; 31(3): 143–147.
  61. Steffen P, Seeling W, Reiser A, et al. [Differential indications for non-opioids for postoperative analgesia III. Analgesic effect of perioperative administration of metamizole plus diclofenac after spinal anesthesia]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1997; 32(8): 496–501.
  62. Steffen P, Seeling W, Kunz R, et al. [Postoperative analgesia after endoscopic abdominal operations. A randomized double-blind study of perioperative effectiveness of metamizole]. Chirurg. 1997; 68(8): 806–810.
  63. Srebrzyński A, Ziółkowski R, Płużańska K, et al. Analiza przeciwbólowego działania metamizolu u chorych operowanych z powodu wola [Analysis of the analgesic effect of metamizole sodium in patients operated on for goitre]. Polish J Surgery. 2008; 80(5): 466–479.
  64. Ohnesorge H, Bein B, Hanss R, et al. Paracetamol versus metamizol in the treatment of postoperative pain after breast surgery: a randomized, controlled trial. Eur J Anaesthesiol. 2009; 26(8): 648–653.
  65. Lauretti GR, Righeti CCf, Kitayama AT. Analgesia after epidural dexamethasone is further enhanced by IV dipyrone, but not IV parecoxibe following minor orthopedic surgery. Korean J Pain. 2014; 27(4): 345–352.
  66. Węgorowski P, Stanisławek A, Domżał-Drzewicka R, et al. The effect of pre-emptive analgesia on the level of postoperative pain in women undergoing surgery for breast neoplasm. Contemp Oncol (Pozn). 2016; 20(2): 158–164.
  67. Neychev D, Chenchev I, Simitchiev K, et al. Analysis of postoperative pain after extraction of impacted mandibular third molars and administration of preemptive analgesia. J of IMAB. 2017; 23(3): 1697–1701.
  68. Favarini VT, Lima CA, da Silva RA, et al. Is dipyrone effective as a preemptive analgesic in third molar surgery? A pilot study. Oral Maxillofac Surg. 2018; 22(1): 71–75.
  69. Suljević I, Hadžiavdić M, Šurković I, et al. The preemptive effect of tramadol and metamizole on the intensity of postoperative pain. Med Glas (Zenica). 2020; 17(2): 285–289.
  70. Stessel B, Lambrechts M, Evers S, et al. Additive or synergistic analgesic effect of metamizole on standard pain treatment at home after arthroscopic shoulder surgery: A randomised controlled superiority trial. Eur J Anaesthesiol. 2023; 40(3): 171–178.
  71. Stasiowski MJ, Lyssek-Boroń A, Zmarzły N, et al. The adequacy of anesthesia guidance for vitreoretinal surgeries with preemptive paracetamol/metamizole. Pharmaceuticals (Basel). 2024; 17(1): 129.
  72. Joshi GP. Rational multimodal analgesia for perioperative pain management. Curr Pain Headache Rep. 2023; 27(8): 227–237.
  73. Striebel HW, Hackenberger J. [A comparison of a tramadol/metamizole infusion with the combination tramadol infusion plus ibuprofen suppositories for postoperative pain management following hysterectomy]. Anaesthesist. 1992; 41(6): 354–360.
  74. Schneider T, Mauermann E, Ilgenstein B, et al. Analgesic benefit of metamizole and ibuprofen vs. either medication alone: a randomized clinical trial. Minerva Anestesiol. 2022; 88(6): 448–456.
  75. Stessel B, Boon M, Pelckmans C, et al. Metamizole vs. ibuprofen at home after day case surgery: A double-blind randomised controlled noninferiority trial. Eur J Anaesthesiol. 2019; 36(5): 351–359.
  76. Samulak D, Michalska M, Gaca M, et al. Efficiency of postoperative pain management after gynecologic oncological surgeries with the use of morphine + acetaminophen + ketoprofen versus morphine + metamizol + ketoprofen. Eur J Gynaecol Oncol. 2011; 32(2): 168–170.
  77. Uzun S, Aycan IO, Erden IA, et al. The addition of metamizole to morphine and paracetamol improves early postoperative analgesia and patient satisfaction after lumbar disc surgery. Turk Neurosurg. 2010; 20(3): 341–347.
  78. Martinez V, Beloeil H, Marret E, et al. Non-opioid analgesics in adults after major surgery: systematic review with network meta-analysis of randomized trials. Br J Anaesth. 2017; 118(1): 22–31.
  79. VigiAccess WHO. https://www.vigiaccess.org/ (13.08.2024).
  80. Zukowski M, Kotfis K. [Safety of metamizole and paracetamol for acute pain treatment]. Anestezjol Intens Ter. 2009; 41(3): 170–175.
  81. Sittl R, Bäumler P, Stumvoll AM, et al. [Considerations concerning the perioperative use of metamizole]. Anaesthesist. 2019; 68(8): 530–537.
  82. Konijnenbelt-Peters J, van der Heijden C, Ekhart C, et al. Metamizole (dipyrone) as an alternative agent in postoperative analgesia in patients with contraindications for nonsteroidal anti-inflammatory drugs. Pain Pract. 2017; 17(3): 402–408.
  83. Stamer UM, Erlenwein J, Freys SM, et al. [Perioperative analgesia with nonopioid analgesics : Joint interdisciplinary consensus-based recommendations of the German Pain Society, the German Society of Anaesthesiology and Intensive Care Medicine and the German Society of Surgery]. Chirurg. 2021; 92(7): 647–663.
  84. Hoenicka M, Gorki H, Traeger K, et al. Selective venous vasodilator properties of the analgesic metamizole (dipyrone) in a human ex vivo model-implications for postoperative pain management. Naunyn Schmiedebergs Arch Pharmacol. 2017; 390(5): 519–526.
  85. Hoenicka M, Stahl L, Datzmann T, et al. Effect of the analgesic metamizole (dipyrone) on volume balance and vasopressor use in cardiac surgery patients. Minerva Anestesiol. 2022; 88(12): 1073–1074.
  86. Avellaneda C, Gómez A, Martos F, et al. The effect of a single intravenous dose of metamizol 2 g, ketorolac 30 mg and propacetamol 1 g on haemodynamic parameters and postoperative pain after heart surgery. Eur J Anaesthesiol. 2000; 17(2): 85–90.
  87. Huber M, Andersohn F, Sarganas G, et al. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case-control surveillance study. Eur J Clin Pharmacol. 2015; 71(2): 219–227.
  88. Stamer UM, Stammschulte T, Erlenwein J, et al. [Recommendations for the perioperative use of dipyrone : Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association]. Schmerz. 2019; 33(4): 287–294.
  89. Tomidis Chatzimanouil MK, Goppelt I, Zeissig Y, et al. Metamizole-induced agranulocytosis (MIA): a mini review. Mol Cell Pediatr. 2023; 10(1): 6.
  90. Lerman TT, Sagi M, Shafir Y, et al. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients. Br J Clin Pharmacol. 2021; 87(7): 2902–2906.
  91. Shah RR. Metamizole (dipyrone)-induced agranulocytosis: does the risk vary according to ethnicity? J Clin Pharm Ther. 2019; 44(1): 129–133.
  92. Cismaru AL, Grimm L, Rudin D, et al. EuDAC Collaborators. High-Throughput sequencing to investigate associations between HLA genes and metamizole-induced agranulocytosis. Front Genet. 2020; 11: 951.
  93. Cismaru AL, Rudin D, Ibañez L, et al. Genome-Wide Association study of metamizole-induced agranulocytosis in european populations. Genes (Basel). 2020; 11(11): 1275.
  94. Kamitani F, Nishioka Y, Koizumi M, et al. Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study. Sci Rep. 2023; 13(1): 19336.
  95. Couto L, Goulart A, Valadão I, et al. Ceftriaxone-induced agranulocytosis. Eur J Case Rep Intern Med. 2021; 8(1): 002215.
  96. Hosack T, Damry D, Biswas S. Drug-induced liver injury: a comprehensive review. Therap Adv Gastroenterol. 2023; 16: 17562848231163410.
  97. Pohl J, Bischoff P, Oellinger R, et al. Liver transplantation for metamizole induced acute liver failure. Transplant Proc. 2022; 54(7): 1854–1858.
  98. Weber S, Benesic A, Neumann J, et al. Liver injury associated with metamizole exposure: features of an underestimated adverse event. Drug Saf. 2021; 44(6): 669–680.
  99. Reike-Kunze M, Zenouzi R, Hartel J, et al. Drug-induced liver injury at a tertiary care centre in Germany: model for end-stage liver disease is the best predictor of outcome. Liver Int. 2021; 41(10): 2383–2395.
  100. Schulte B, Tergast TL, Griemsmann M, et al. Metamizole-associated risks in decompensated hepatic cirrhosis. Dtsch Arztebl Int. 2022; 119(41): 687–693.
  101. Bachmann F, Meyer Zu Schwabedissen HE, Duthaler U, et al. Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine. Br J Clin Pharmacol. 2022; 88(4): 1885–1896.
  102. Watermeyer F, Gaebler AJ, Neuner I, et al. Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders. Br J Clin Pharmacol. 2021; 87(3): 1111–1119.
  103. Lameiras C, Corte-Real A, Órfão A, et al. Metamizole-Induced type I Kounis syndrome. Eur J Case Rep Intern Med. 2021; 8(3): 002249.
  104. Gomes Ferreira S, Fernandes L, Santos S, et al. Dipyrone (metamizole)-induced Stevens-Johnson syndrome. Cureus. 2024; 16(1): e53122.
  105. Jipa M, Isac S, Klimko A, et al. Opioid-sparing analgesia impacts the perioperative anesthetic management in major abdominal surgery. Medicina (Kaunas). 2022; 58(4): 487.
  106. Cetira-Filho EL, Martins-Filho PR, de Barros Silva PG, et al. Is coadministration of preemptive medications an effective strategy for reducing inflammatory clinical events and the need for rescue medication after mandibular third molar surgery? A systematic review of randomized clinical trials. Inflammopharmacology. 2023; 31(4): 1561–1575.
  107. Katz N, Paillard FC, Van Inwegen R. A review of the use of the number needed to treat to evaluate the efficacy of analgesics. J Pain. 2015; 16(2): 116–123.
  108. Hearn L, Derry S, Moore RA. Single dose dipyrone (metamizole) for acute postoperative pain in adults. Cochrane Database Syst Rev. 2016; 4(4): CD011421.
  109. Lux EA, Stamer U, Meissner W, et al. [Postoperative pain management after ambulatory surgery. A survey of anaesthesiologists]. Schmerz. 2011; 25(2): 191–194, 197–198.
  110. Reist L, Erlenwein J, Meissner W, et al. Dipyrone is the preferred nonopioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German-speaking countries. Eur J Pain. 2018; 22(6): 1103–1112.
  111. Vilcane S, Scharonow O, Weilbach C, et al. Application of analgesics in emergency services in Germany: a survey of the medical directors. BMC Emerg Med. 2023; 23(1): 104.
  112. Ponholzer F, Schweiger T, Ghanim B, et al. Analysis of pain management after anatomic VATS resection in austrian thoracic surgery units. J Clin Med. 2023; 13(1): 80.
  113. Grossman R, Ram Z, Perel A, et al. Control of postoperative pain after awake craniotomy with local intradermal analgesia and metamizol. Isr Med Assoc J. 2007; 9(5): 380–382.
  114. Mestdagh FP, Lavand'homme PM, Pirard G, et al. PROSPECT Working Group∗ of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after elective craniotomy: a systematic review with procedure-specific postoperative pain management (PROSPECT) recommendations. Eur J Anaesthesiol. 2023; 40(10): 747–757.
  115. Silva F, Costa G, Veiga F, et al. Parenteral ready-to-use fixed-dose combinations including nsaids with paracetamol or metamizole for multimodal analgesia-approved products and challenges. Pharmaceuticals (Basel). 2023; 16(8): 1084.
  116. Costa FW, Esses DF, de Barros Silva PG, et al. Does the preemptive use of oral nonsteroidal anti-inflammatory drugs reduce postoperative pain in surgical removal of third molars? A meta-analysis of randomized clinical trials. Anesth Prog. 2015; 62(2): 57–63.
  117. Maytalman E, Nemutlu Samur D. Neuroendocrine modulation by metamizole and indomethacin: investigating the impact on neuronal markers and GnRH release. Endocrine. 2024; 85(3): 1327–1336.
  118. Ji RR, Nackley A, Huh Y, et al. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018; 129(2): 343–366.
  119. Fuller AM, Bharde S, Sikandar S. The mechanisms and management of persistent postsurgical pain. Front Pain Res (Lausanne). 2023; 4: 1154597.
  120. Schumacher MA. Peripheral neuroinflammation and pain: how acute pain becomes chronic. Curr Neuropharmacol. 2024; 22(1): 6–14.
  121. Bernal A, Arranz L. Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cell Mol Life Sci. 2018; 75(12): 2177–2195.
  122. Martínez C, Andreu I, Amo G, et al. Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole. Biochem Pharmacol. 2014; 92(3): 457–466.
  123. Szałek E, Spychala A, Kozanecka P, et al. The metabolic conversion of metamizole (Dipyrone) in male and female patients after total gastrectomy for stomach cancer. Acta Poloniae Pharmaceutica - Drug Research. 2022; 79(3): 401–407.
  124. Chaparro LE, Lezcano W, Alvarez HD, et al. Analgesic effectiveness of dipyrone (metamizol) for postoperative pain after herniorrhaphy: a randomized, double-blind, dose-response study. Pain Pract. 2012; 12(2): 142–147.
  125. Baca Q, Marti F, Poblete B, et al. Predicting acute pain after surgery: a multivariate analysis. Ann Surg. 2021; 273(2): 289–298.
  126. Misiołek H, Zajączkowska R, Daszkiewicz A, et al. Postoperative pain management - 2018 consensus statement of the Section of Regional Anaesthesia and Pain Therapy of the Polish Society of Anaesthesiology and Intensive Therapy, the Polish Society of Regional Anaesthesia and Pain Therapy, the Polish Association for the Study of Pain and the National Consultant in Anaesthesiology and Intensive Therapy. Anaesthesiol Intensive Ther. 2018; 50(3): 173–199.
  127. Wordliczek J, Zajączkowska R, Dziki A, et al. Postoperative pain relief in general surgery — recommendations of the Association of Polish Surgeons, Polish Society of Anaesthesiology and Intensive Therapy, Polish Association for the Study of Pain and Polish Association of Regional Anaesthesia and Pain Treatment. Pol Przegl Chir. 2019; 91(1): 47–68.
  128. Stamer UM, Erlenwein J, Freys SM, et al. [Perioperative analgesia with nonopioid analgesics : Joint interdisciplinary consensus-based recommendations of the German Pain Society, the German Society of Anaesthesiology and Intensive Care Medicine and the German Society of Surgery]. Anaesthesist. 2021; 70(8): 689–705.
  129. Schug S, Pogatzki-Zahn E, Phillips LD, et al. Multi-Criteria decision analysis to develop an efficacy-safety profile of parenteral analgesics used in the treatment of postoperative pain. J Pain Res. 2020; 13: 1969–1977.
  130. Dusch M. [Perioperative pain management — patient information, informed consent and discharge management]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2021; 56(9): 574–585.
  131. Fritsch G, Steltzer H, Oberladstaetter D, et al. Artificial intelligence algorithms predict the efficacy of analgesic cocktails prescribed after orthopedic surgery. PLoS One. 2023; 18(2): e0280995.
  132. Machado-Alba JE, Serna-Echeverri LS, Valladales-Restrepo LF, et al. Use of tramadol or other analgesics in patients treated in the emergency department as a risk factor for opioid use. Pain Res Manag. 2020; 2020: 8847777.
  133. Keane A, Jardine K, Goldenberg D, et al. Opioid versus non-opioid postoperative pain management in otolaryngology. BMC Anesthesiol. 2023; 23(1): 291.
  134. Barden J, Edwards JE, McQuay HJ, et al. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol. 2003; 3(1): 1.
  135. Schug SA, Scott DA, Mott JF, Halliwell R, Palmer GM, Alcock M. Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute pain management: scientific evidence (5th edition). ANZCA & FPM, Melbourne 2020.